ISSN 1004-4140
CN 11-3017/P
| Citation: |
MA Z Z, SHENG Y D, YANG K, et al. HRCT Features of Dermatomyositis-/Polymyositis- Associated Interstitial Lung Disease[J]. CT Theory and Applications, 2024, 33(4): 497-502. DOI: 10.15953/j.ctta.2023.131. (in Chinese).
|
Objective: To evaluate high-resolution computed tomography (HRCT) features of dermatomyositis-/polymyositis- associated interstitial lung disease (DM/PM-ILD). Methods: We retrospectively reviewed the HRCT images of 148 patients with DM/PM-ILD at the First Affiliated Hospital of Xi’an Jiaotong University between Jan. 1, 2014, and Dec. 31, 2019. Results: The HRCT features of DM/PM-ILD were characterized by ground-glass opacities (GGO) (87.2%, 123/141), interlobular septal thickening (78.0%, 110/141), intralobular interstitial thickening (63.8%, 90/141), consolidation (29.1%, 41/141), subpleural lines (26.2%, 37/141), traction bronchiectasis (19.9%, 28/141), and honeycombing (3.5%, 5/141). Pneumomediastinum (3), pleural effusion (15), and pericardial effusion (18) were also observed. The two main radiological patterns were non-specific interstitial pneumonia (NSIP) and organism pneumonia (OP). Conclusion: HRCT features of DM/PM-ILD are heterogeneous, with various radiological patterns. Mastering the main characteristics of HRCT manifestation and the radiological patterns of DM/PM-ILD will be helpful for early identification and timely treatment.
| [1] |
王亚飞, 李红霞, 吴振彪. 肌炎相关间质性肺病的治疗进展[J]. 中华风湿病学杂志, 2022, 26(7): 480−485. DOI: 10.3760/cma.j.cn141217-20210927-00392.
WANG Y F, LI H X, WU Z B. Progress in the treatment of myositis-related interstitial lung disease[J]. Chinese Journal of Rheumatology, 2022, 26(7): 480−485. DOI: 10.3760/cma.j.cn141217-20210927-00392. (in Chinese).
|
| [2] |
PALMUCCI S, Di MARI A, CANCEMI G, et al. Clinical and radiological features of interstitial Lung diseases associated with polymyositis and dermatomyositis[J]. Medicina (Kaunas), 2022, 58(12): 1757. DOI: 10.3390/medicina58121757.
|
| [3] |
吴京波, 时新杰, 郭丽娟, 等. 以间质性肺病为首发表现的抗Jo-1抗体综合征1例[J]. 国际医药卫生导报, 2021, 27(8): 1240−1243. DOI: 10.3760/cma.j.issn.1007-1245.2021.08.034.
WU J B, SHI X J, GUO L J, et al. One case of anti-Jo-1 syndrome with interstitial lung disease as the initial symptom[J]. International Medicine and Health Guidance News, 2021, 27(8): 1240−1243. DOI: 10.3760/cma.j.issn.1007-1245.2021.08.034. (in Chinese).
|
| [4] |
SUGIYAMA Y, YOSHIMI R, TAMURA M, et al. The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease[J]. Arthritis Research & Therapy, 2018, 20(1): 7. DOI: 10.1186/s13075-017-1506-7.
|
| [5] |
GULER S A, CORTE T J. Interstitial lung disease in 2020: A history of progress[J]. Clinics in Chest Medicine, 2021, 42(2): 229−239. DOI: 10.1016/j.ccm.2021.03.001.
|
| [6] |
BOHAN A, PETER J B. Polymyositis and dermatomyositis (first of two parts)[J]. The New England Journal of Medicine, 1975, 292(7): 344−347. DOI: 10.1056/NEJM197502132920706.
|
| [7] |
OLIVEIRA D S, ARAÚJO FILHO J A, PAIVA A, et al. Idiopathic interstitial pneumonias: Review of the latest American Thoracic Society/European Respiratory Society classification[J]. Radiologia Brasileira, 2018, 51(5): 321−327. DOI: 10.1590/0100-3984.2016.0134.
|
| [8] |
HANSELL D M, BANKIER A A, MACMAHON H, et al. Fleischner Society: Glossary of terms for thoracic imaging[J]. Radiology, 2008, 246(3): 697−722. DOI: 10.1148/radiol.2462070712.
|
| [9] |
GUAN C S, LV Z B, YAN S, et al. Imaging features of coronavirus disease 2019 (COVID-19): Evaluation on thin-section CT[J]. Academic Radiology, 2020, 27(5): 609−613. DOI: 10.1016/j.acra.2020.03.002.
|
| [10] |
EGASHIRA R. High-resolution CT findings of myositis-related interstitial lung disease[J]. Medicina (Kaunas), 2021, 57(7): 692. DOI: 10.3390/medicina57070692.
|
| [11] |
KIM G, TASHKIN D P, LO P, et al. Using transitional changes on high-resolution computed tomography to monitor the impact of cyclophosphamide or mycophenolate mofetil on systemic sclerosis-related interstitial lung disease[J]. Arthritis & Rheumatology, 2020, 72(2): 316−325. DOI: 10.1002/art.41085.
|
| [12] |
GOLDIN J G, KIM G, TSENG C H, et al. Longitudinal changes in quantitative interstitial lung disease on computed tomography after immunosuppression in the scleroderma lung study II[J]. Annals of the American Thoracic Society, 2018, 15(11): 1286−1295. DOI: 10.1513/AnnalsATS.201802-079OC.
|
| [13] |
KISHABA T. Acute exacerbation of idiopathic pulmonary fibrosis[J]. Medicina (Kaunas), 2019, 55(3): 70. DOI: 10.3390/medicina55030070.
|
| [14] |
毛萌萌, 郭炳鹏, 韩茜. 《成人特发性肺纤维化(更新)和进展性肺纤维化: ATS/ERS/JRS/ALAT临床实践指南(2022版)》解读(一): 进展性肺纤维化识别与治疗[J]. 国际呼吸杂志, 2023, 43(11): 1245−1250. DOI: 10.3760/cma.j.cn131368-20231013-00247.
MAO M M, GUO B P, HAN Q. Interpretation of “Idiopathic pulmonary fibrosis (an Update) and progressive pulmonary fibrosis in adults: An official ATS/ERS/JRS/ALAT clinical practice guideline (2022 Edition)”: Identification and treatment of progressive pulmonary fibrosis[J]. International Journal of Respiration, 2023, 43(11): 1245−1250. DOI: 10.3760/cma.j.cn131368-20231013-00247. (in Chinese).
|
| [15] |
HAYASHI S, TANAKA M, KOBAYASHI H, et al. High-resolution computed tomography characterization of interstitial lung diseases in polymyositis/dermatomyositis[J]. The Journal of Rheumatology, 2008, 35(2): 260−269.
|
| [16] |
SINGH D, KUMAR S, STEAD T S, et al. Spontaneous mediastinal emphysema[J]. Cureus, 2018, 10(3): e2369. DOI: 10.7759/cureus.2369.
|
| [17] |
YEUNG T W, CHEONG K N, LAU Y L, et al. Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: A case report and literature review[J]. Pediatric Rheumatology Online Journal, 2021, 19(1): 103. DOI: 10.1186/s12969-021-00595-1.
|
| [18] |
郭子维, 王燕, 胡伟, 等. 皮肌炎合并纵隔气肿患者的临床特点及血清学特征[J]. 中华风湿病学杂志, 2015, 19(9): 592−597. DOI: 10.3760/cma.j.issn.1007-7480.2015.09.004.
GUO Z W, WANG Y, HU W, et al. Clinical and serological features of patients with dermatomyositis complicated by spontaneous pneumomediastinum[J]. Chinese Journal of Rheumatology, 2015, 19(9): 592−597. DOI: 10.3760/cma.j.issn.1007-7480.2015.09.004. (in Chinese).
|
| [19] |
YOO H, HINO T, HAN J, et al. Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management[J]. European Journal of Radiology Open, 2021, 8: 100311. DOI: 10.1016/j.ejro.2020.100311.
|
| [20] |
DOUGLAS W W, TAZELAAR H D, HARTMAN T E, et al. Polymyositis-dermatomyositis-associated interstitial lung disease[J]. American Journal of Respiratory and Critical Care Medicine, 2001, 164(7): 1182−1185. DOI: 10.1164/ajrccm.164.7.2103110.
|
| [21] |
JOY G M, ARBIV O A, WONG C K, et al. Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: A systematic review and meta-analysis[J]. European Respiratory Review: An Official Journal of the European Respiratory Society, 2023, 32(167). DOI: 10.1183/16000617.0210-2022.
|
Supported by: Beijing Renhe Information Technology Co. Ltd 
DownLoad: